Print Friendly Page

Protocol No. S1501

Phase III

Age Group Adult

Scope National

Sponsor Type National

Title S1501: Prospective Evaluation in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

Applicable Disease Sites Breast

Drugs Involved Coreg (carvedilol); carvedilol

Status Open (affiliates only)

Participating Institutions Bellin Memorial Hospital/Cancer Team at Bellin Health